DK0984936T3 - Cyanoguanidiner som celleproliferationsinhibitorer - Google Patents

Cyanoguanidiner som celleproliferationsinhibitorer

Info

Publication number
DK0984936T3
DK0984936T3 DK98924052T DK98924052T DK0984936T3 DK 0984936 T3 DK0984936 T3 DK 0984936T3 DK 98924052 T DK98924052 T DK 98924052T DK 98924052 T DK98924052 T DK 98924052T DK 0984936 T3 DK0984936 T3 DK 0984936T3
Authority
DK
Denmark
Prior art keywords
stands
cyanoguanidines
alkoxycarbonyl
carboxy
alkoxy
Prior art date
Application number
DK98924052T
Other languages
English (en)
Inventor
Charlotte Schou
Erik Rytter Ottosen
Original Assignee
Leo Pharma As With Secondary N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As With Secondary N filed Critical Leo Pharma As With Secondary N
Application granted granted Critical
Publication of DK0984936T3 publication Critical patent/DK0984936T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98924052T 1997-05-29 1998-05-15 Cyanoguanidiner som celleproliferationsinhibitorer DK0984936T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711123.1A GB9711123D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000193 WO1998054141A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
DK0984936T3 true DK0984936T3 (da) 2004-01-05

Family

ID=10813253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924052T DK0984936T3 (da) 1997-05-29 1998-05-15 Cyanoguanidiner som celleproliferationsinhibitorer

Country Status (21)

Country Link
US (2) US6346520B1 (da)
EP (1) EP0984936B1 (da)
JP (1) JP4349476B2 (da)
KR (1) KR100549631B1 (da)
CN (1) CN1121389C (da)
AT (1) ATE248819T1 (da)
AU (1) AU733000B2 (da)
CA (1) CA2292775C (da)
CZ (1) CZ293275B6 (da)
DE (1) DE69817810T2 (da)
DK (1) DK0984936T3 (da)
ES (1) ES2206931T3 (da)
GB (1) GB9711123D0 (da)
HK (1) HK1027568A1 (da)
HU (1) HUP0003823A3 (da)
NZ (1) NZ501266A (da)
PL (1) PL190249B1 (da)
PT (1) PT984936E (da)
RO (1) RO119880B1 (da)
RU (1) RU2194697C2 (da)
WO (1) WO1998054141A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4080300A (en) 1999-04-09 2000-11-14 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
BR0209930A (pt) * 2001-05-24 2004-03-30 Leo Pharma As Composto, composição farmacêutica, método para tratar doenças proliferativas, e, uso de um composto
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
JP5189367B2 (ja) 2004-12-22 2013-04-24 レオ ファーマ アクティーゼルスカブ 新規シアノグアニジン化合物
EP2197443A4 (en) 2007-09-26 2014-01-01 Gemin X Pharmaceuticals Canada Inc COMPOSITIONS AND METHODS FOR INFLUENCING NAD + CONTENT USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE INHIBITOR
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
AU2010210248B2 (en) * 2009-02-06 2012-08-16 Tianjin Hemay Bio-Tech Co., Ltd. Pharmaceutical compositions comprising pyridyl cyanoguanidine, process for preparing the same and use thereof
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
WO2012055346A1 (zh) 2010-10-26 2012-05-03 天津和美生物技术有限公司 N-(6-(4-氯苯氧基)己基)-n'-氰基-n''-(4-吡啶基)胍的多晶型物及其制备和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
GB9711125D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
AU1494702A (en) * 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs

Also Published As

Publication number Publication date
EP0984936B1 (en) 2003-09-03
EP0984936A1 (en) 2000-03-15
CN1121389C (zh) 2003-09-17
GB9711123D0 (en) 1997-07-23
WO1998054141A1 (en) 1998-12-03
US6646129B2 (en) 2003-11-11
KR100549631B1 (ko) 2006-02-08
CZ9904240A3 (cs) 2001-01-17
ATE248819T1 (de) 2003-09-15
CZ293275B6 (cs) 2004-03-17
CN1258277A (zh) 2000-06-28
HK1027568A1 (en) 2001-01-19
JP4349476B2 (ja) 2009-10-21
PL190249B1 (pl) 2005-11-30
KR20010013164A (ko) 2001-02-26
HUP0003823A3 (en) 2001-09-28
PL337059A1 (en) 2000-07-31
US6346520B1 (en) 2002-02-12
DE69817810T2 (de) 2004-07-01
CA2292775C (en) 2009-10-13
AU7638398A (en) 1998-12-30
CA2292775A1 (en) 1998-12-03
NZ501266A (en) 2001-09-28
DE69817810D1 (de) 2003-10-09
HUP0003823A2 (en) 2001-03-28
ES2206931T3 (es) 2004-05-16
RO119880B1 (ro) 2005-05-30
RU2194697C2 (ru) 2002-12-20
US20020107400A1 (en) 2002-08-08
JP2001526692A (ja) 2001-12-18
AU733000B2 (en) 2001-05-03
PT984936E (pt) 2004-02-27

Similar Documents

Publication Publication Date Title
SE0202463D0 (sv) Novel compounds
DK0984938T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
NO20066055L (no) Pyridinderivater
HK1080470A1 (en) Heterocyclic compounds
DE60226469D1 (de) Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
HK1053463A1 (en) Aminobenzophenones as inhibitors of il-1B and TNF-a.
IL166271A0 (en) Pyrrolidinedione substituted piperidine phthalazone derivatives and pharmaceutical compositions containing the same
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
DE60334536D1 (de) Furylverbindungen
DE60333746D1 (de) Thienylverbindungen
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
DK0984936T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
BRPI0407841A (pt) inibidores heterocìclicos de quinase
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
SE0302756D0 (sv) Novel Compounds
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
SE0202461D0 (sv) Novel compounds
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren